GHAPPcast: Biosimilars and the Patient Perspective
GHAPPcast17 Syys 2024

GHAPPcast: Biosimilars and the Patient Perspective

Thank you to Boehringer Ingelheim for your support of this podcast.

Welcome to GHAPPcast, the official podcast for gastroenterology and hepatology advanced practice providers. Hosted by Gabriella McCarty, a nurse practitioner at NorthShore Gastroenterology in Cleveland, this episode dives into a crucial topic—biosimilars from a patient’s perspective. As a founding member of GHAPP and a provider with 25 years of experience in general GI, IBD, and hepatology, Gabriella is excited to explore the real-world impact of biosimilars through the eyes of a patient.

In this episode, we welcome Emily, a Crohn’s disease patient who has firsthand experience transitioning to and from biosimilars. She shares her journey, initial concerns, and how switching medications impacted her health. With insurance-driven transitions from Remicade to Inflectra and back, Emily provides valuable insights into the realities of biosimilar treatment, debunking misconceptions, and highlighting the importance of open communication with healthcare providers.

For patients, providers, and caregivers navigating biosimilar treatments, this discussion offers a unique perspective on the transition process, medication efficacy, and long-term remission maintenance. Whether you’re a clinician seeking to guide patients or someone facing a biosimilar switch, this episode provides essential takeaways for ensuring a smooth and informed treatment journey.

Subscribe to GHAPP for more expert insights into gastroenterology, hepatology, IBD, and patient-centered care. Visit ghapp.org and download the GHAPP ACE app for more educational content.

Tämä jakso on lisätty Podme-palveluun avoimen RSS-syötteen kautta eikä se ole Podmen omaa tuotantoa. Siksi jakso saattaa sisältää mainontaa.

Jaksot(154)

Medication Review: Guselkumab IV vs SC Formulation

Medication Review: Guselkumab IV vs SC Formulation

Thank you to Johnson & Johnson for their support on this Medication Review Video Module. In this quick educational video, Angelina Collins, NP, from the University of California San Diego Inflammatory...

28 Touko 3min

FAQ: Recognizing OHE Risk in Patients with Chronic Liver Disease

FAQ: Recognizing OHE Risk in Patients with Chronic Liver Disease

Thank you to Salix for the support on this FAQ Video Module.This educational FAQ module, featuring Mikhail Alper, PA-C focuses on recognizing risk factors and early clinical indicators of Overt Hepati...

26 Touko 2min

FAQ: Phase 3 GALAXI 2 & 3: Extraintestinal Manifestations In Moderate to Severe Crohn’s Disease

FAQ: Phase 3 GALAXI 2 & 3: Extraintestinal Manifestations In Moderate to Severe Crohn’s Disease

Thank you to Johnson & Johnson for the support on this FAQ Video Module.This FAQ video features Janette Villalon, PA, who reviews the role of guselkumab in treating extraintestinal manifestations in p...

19 Touko 5min

Medication Review: Monotherapy vs. Combination Therapy: Relevance in IBD Treatment Strategy

Medication Review: Monotherapy vs. Combination Therapy: Relevance in IBD Treatment Strategy

Thank you to Celltrion for the support on this Medication Review Video Module.This medication review explores the evolving role of monotherapy versus combination therapy in the treatment of inflammato...

14 Touko 3min

Medication Review: Stable PK Supporting Continuous Inflammatory Control

Medication Review: Stable PK Supporting Continuous Inflammatory Control

Thank you to Celltrion for the support on this Medication Review Video Module.This medication review explores the role of stable pharmacokinetics (PK) in achieving continuous inflammatory control in i...

7 Touko 6min

Journal Club: ASTRO Phase 3 Study: Efficacy and Safety of SC Guselkumab

Journal Club: ASTRO Phase 3 Study: Efficacy and Safety of SC Guselkumab

Thank you to Johnson & Johnson for the support on this Journal Club Review Module.In this journal club video, Sharon Dudley Brown, CRNP, PhD, from the IBD Center at Johns Hopkins University, reviews t...

28 Huhti 5min

Journal Club: Benefit–Risk Profile of Upadacitinib in Patient’s With Moderate to Severe UC and CD

Journal Club: Benefit–Risk Profile of Upadacitinib in Patient’s With Moderate to Severe UC and CD

Thank you to AbbVie for the support on this Journal Club Review Module.This journal club review episode explores the benefit–risk profile of Upadacitinib for patients with moderately to severely activ...

21 Huhti 23min

Podcast: How Do You Best Support Patients Getting Started on New MASH Treatments?

Podcast: How Do You Best Support Patients Getting Started on New MASH Treatments?

Learn how to effectively support patients starting treatment for MASH with this practical, clinician-focused discussion featuring expert advanced practice providers. In this episode, hepatology specia...

14 Huhti 18min

Suosittua kategoriassa Terveys ja hyvinvointi

unicast
rss-pitaisko-erota
psykopodiaa-podcast
vakeva-elama-viisaampi-mieli-vahvempi-keho
tiedenaiset-podcast
voi-hyvin-meditaatiot-2
puhu-muru
rss-kuumilla-aalloilla
rss-pt-paahtio
rss-narsisti
meditaatiot-suomeksi
terapiassa
rss-uplevel-by-sonja-hannus
katilon-kahvitunti
fitnessvastaanotto
paritellen
rss-nautinto
rss-terapiaklubi
junnut-pelissa
monisuhteellista